We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PID:NASDAQInvesco International Dividend Achievers ETF Analysis

Data as of 2026-05-19 - not real-time

$22.92

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The ETF shows a bullish price trend, with the 20‑day SMA (22.76) comfortably above both 50‑day (22.59) and 200‑day (22.08) averages, and the MACD histogram turning positive, indicating upward momentum.
However, volatility over the past 30 days is elevated at ~12 %, and volume is on a decreasing trend, suggesting emerging liquidity pressure despite a low expense ratio (0.53 %) and zero tracking error.
The fund’s dividend yield (~3.3 %) and extreme‑greed sentiment (FGI 89.18) support a short‑ to medium‑term income case, while the modest max drawdown (~‑8 %) and beta (<0.5) keep overall risk moderate.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • bullish MACD and positive histogram
  • price trading above key SMAs
  • decreasing volume trend raising short‑term liquidity caution

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • stable dividend yield (~3.3 %) providing income
  • low expense ratio (0.53 %) enhancing net return
  • extreme‑greed market sentiment indicating upside potential

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • moderate volatility (12 % 30‑day) within acceptable range
  • max drawdown around ‑8 % limiting downside risk
  • low beta (0.47) and diversified foreign large‑value exposure

Key Metrics & Analysis

Fund Metrics

Expense Ratio0.53%
AUM$928.6M
Inception Date2005-09-15
Avg Daily Volume41,790
Premium/Discount0.00%
Tracking Error0.00%
Dividend Yield3.28%

Technical Analysis

TrendBullish
RSI55.1
Support$22.32
Resistance$23.05
MA 20$22.76
MA 50$22.59
MA 200$22.08
MACDBullish
VolumeDecreasing
Fear & Greed Index89.18

Risk Assessment

Beta0.47
Volatility12.15%
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.